Medizinische Klinik für Gastroenterologie, Infektiologie, Rheumatologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Lancet Gastroenterol Hepatol. 2017 May;2(5):369-376. doi: 10.1016/S2468-1253(16)30159-5.
Refractory colitis in patients with inflammatory bowel disease is a complicated clinical disorder that might, in some patients, even necessitate surgery. Hence the diagnosis of additional complications is of utmost importance. Colitis mediated by cytomegalovirus is one such complication. The high seroprevalence and latent nature of cytomegalovirus, with the possibility of viral replication without mediating disease, poses a real challenge for the diagnosis of cytomegalovirus-mediated colitis. The challenge in daily clinical practice is to distinguish cytomegalovirus replication from cytomegalovirus-mediated colitis in patients with inflammatory bowel disease who have refractory colitis. This Review discusses the scientific literature and provides a diagnostic and therapeutic algorithm for clinical practice.
炎症性肠病患者的难治性结肠炎是一种复杂的临床疾病,在某些患者中甚至可能需要手术。因此,诊断其他并发症至关重要。巨细胞病毒引起的结肠炎就是其中一种并发症。巨细胞病毒的高血清阳性率和潜伏性,以及可能在不引起疾病的情况下复制病毒,给巨细胞病毒介导的结肠炎的诊断带来了真正的挑战。在日常临床实践中的挑战是区分炎症性肠病患者难治性结肠炎时巨细胞病毒的复制与巨细胞病毒介导的结肠炎。本文综述了科学文献,并为临床实践提供了诊断和治疗算法。